Praan Naturals introduces Tagua Seed Powder to natural ingredient portfolio
Praan Naturals introduces Tagua Seed Powder (INCI: Phytelephas Aequatorialis (Tagua) Seed Powder) as a key ingredient in its natural ingredient portfolio.
Praan Naturals Tagua Seed Powder is an environmentally responsible, natural alternative to synthetic exfoliants and skin lighteners, according to the company. It is produced from 100% pure, ethically harvested tagua seeds. The powder contains no added fillers or other materials.
Tagua seeds, also known as vegetable ivory, are considered a plant-based alternative to ivory due to the strength of the material and ivory-like texture. When ground into a fine powder, tagua seeds create a pure white plant-based exfoliant suitable for use in cleansers and exfoliants, the company says.
Anáil Moon Devī, CEO of Praan Naturals, commented: "Praan Naturals Tagua Seed Powder is a derivative (secondary) product made from the taguan seed fragments left over from the production of buttons and decorations by community artisans in Ecuador. Grinding these leftover pieces into powder ensures that none of the beneficial seed material is wasted. "
Praan Naturals' manufacturing partners support local indigenous communities, participate in Fair Trade, and are FairWild certified.
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Praan Naturals Presents Organic Virgin Date Kernel Oil for Skin and Hair Health
-
Sweegen will launch a new high-intensity sweetener, FoodTalks announced the top 20 global food preservative companies in 2021
-
ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk
-
Trump Slaps 25 Percent Tariff on Indian Imports US Shrimp Imports Hit with 33 Percent Total Levy
-
US MDI Supply Squeeze Triggers Price Hikes
-
Bolivia Uncovers 23 New Egg Smuggling Routes Weekly Contraband Soars to 12 Million Eggs
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
Mounjaro Reduces Heart Events by 8 Percent More Than Trulicity in 13,000-Patient Diabetes Trial
-
JB Pharma Q1 Net Profit Surges 14 Percent to ₹202 Crore Revenue Hits ₹1094 Crore with 30 Percent EBITDA Margin
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
Recommend Reading
-
Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Kao Launches Tertiary Amine Production in the U.S.
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Premium Global Chemical Sourcing Requests (23–27 Aug 2025)
-
June 8th: Shandong Asphalt Supply Declines, Market Continues to Rise
-
Supply Pressure Doubles, Hydrogen Peroxide Prices Continue to Fall in China
-
Moving Average Crossover, June Isooctanol Prices in China Rise
-
Palm Oil Market in August Shows Volatile Rise